Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)

被引：0
|
作者：
Chaibi, P [1 ]
Dombret, H [1 ]
Rousselot, P [1 ]
Gardin, C [1 ]
Glaisner, S [1 ]
Castaigne, S [1 ]
Degos, L [1 ]
机构：
[1] HOP ST LOUIS,SERV CLIN MALAD SANG,PARIS,FRANCE
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：822 / 822
页数：1
相关论文
共 50 条
  • [41] The Results of Chemotherapy for the Elderly Acute Myelogenous Leukemia Patients
    Kim, Daesik
    Park, Yong
    Lee, Suk-young
    Lee, Se Ryeon
    Sung, Hwa Jung
    Kim, Seok Jin
    Kim, Byung Soo
    Choi, Chulwon
    BLOOD, 2012, 120 (21)
  • [42] Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia
    Attar, Eyal C.
    De Angelo, Daniel J.
    Supko, Jeffrey G.
    D'Amato, Ferdinando
    Zahrieh, David
    Sirulnik, Andres
    Wadleigh, Martha
    Ballen, Karen K.
    McAfee, Steve
    Miller, Kenneth B.
    Levine, James
    Galinsky, Ilene
    Trehu, Elizabeth G.
    Schenkein, David
    Neuberg, Donna
    Stone, Richard M.
    Amrein, Philip C.
    CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1446 - 1454
  • [43] MGA GUIDED INTENSIVE INDUCTION WITH HIGH DOSE CYTARABINE PLUS IDARUBICIN IN 149 AML ELDERLY PATIENTS
    Capelli, D.
    Saraceni, F.
    Chiarucci, M.
    Poloni, A.
    Discepoli, G.
    Leoni, P.
    Olivieri, A.
    HAEMATOLOGICA, 2015, 100 : 43 - 43
  • [44] Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML
    Uy, Geoffrey L.
    Rettig, Michael P.
    Fletcher, Theresa
    Riedell, Peter A.
    Stockerl-Goldstein, Keith E.
    Ghobadi, Armin
    Jacoby, Meagan
    Cashen, Amanda F.
    Romee, Rizwan
    Pusic, Iskra
    Abboud, Camille N.
    Schroeder, Mark A.
    Vij, Ravi
    Westervelt, Peter
    DiPersio, John F.
    BLOOD, 2017, 130
  • [45] Phase II Study of Cladribine, Idarubicin, and Cytarabine (araC) in Patients with Acute Myeloid Leukemia (AML)
    Kadia, Tapan
    Cortes, Jorge E.
    Jabbour, Elias J.
    Daver, Naval
    Pemmaraju, Naveen
    Ravandi, Farhad
    Jain, Nitin
    Verstovsek, Srdan
    DiNardo, Courtney
    Alvarado, Yesid
    Ferrajoli, Alessandra
    Burger, Jan A.
    Garcia-Manero, Guillermo
    Ohanian, Maro
    Konopleva, Marina
    Estrov, Zeev
    Wierda, William
    Brandt, Mark
    Fitch, Tina
    Borthakur, Gautam
    Kantarjian, Hagop M.
    BLOOD, 2015, 126 (23)
  • [46] Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
    Montillo, M
    Mirto, S
    Petti, MC
    Latagliata, R
    Magrin, S
    Pinto, A
    Zagonel, V
    Mele, G
    Tedeschi, A
    Ferrara, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (02) : 105 - 109
  • [47] A Phase II Expansion Study of Vorinostat in Combination With Idarubicin and Cytarabine for Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations
    Takahashi, Koichi
    Jabbour, Elias
    Ravandi, Farhad
    Borthakur, Gautam
    Cortes, Jorge
    Kadia, Tapan
    O'Brien, Susan
    Thomas, Deborah
    Faderl, Stefan
    Bass, Joyce
    Wierda, William
    Daver, Naval
    Dinardo, Courtney
    Pierce, Sherry
    Brandt, Mark
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S123 - S123
  • [48] A Phase II Expansion Study Of Vorinostat In Combination With Idarubicin and Cytarabine For Patients With Acute Myelogenous Leukemia (AML) With FLT3 Molecular Alterations
    Takahashi, Koichi
    Jabbour, Elias
    Ravandi, Farhad
    Borthakur, Gautam
    Cortes, Jorge E.
    Kadia, Tapan
    O'Brien, Susan
    Thomas, Deborah A.
    Faderl, Stefan
    Bass, Joyce
    Wierda, William G.
    Daver, Naval
    DiNardo, Courtney D.
    Pierce, Sherry
    Brandt, Mark
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2013, 122 (21)
  • [49] Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
    Garcia-Manero, Guillermo
    Tambaro, Francesco Paolo
    Bekele, Nebiyou
    Yang, Rui
    Ravandi, Farhad
    Jabbour, Elias
    Borthakur, Gautam
    Kadia, Tapan
    Konopleva, Marina
    Faderl, Stefan
    Cortes, Jorge E.
    Brandt, Mark
    Hu, Yumin
    McCue, Deborah
    Newsome, Willie Mae
    Pierce, Sherry
    DeLima, Marcos
    Kantarjian, Hagop M.
    BLOOD, 2011, 118 (21) : 346 - 347
  • [50] G-CSF treatment in acute leukemia
    S Savaşan
    E Abella
    AJ Akhtar
    Y Ravindranath
    Leukemia, 1997, 11 : 2210 - 2211
12345